Valproic acid toxicity mimicking multiple system atrophy

Neurology

Volumn 55, Issue 12, 2000, Pages 1936-1937

  Shill, Holly A ^a   Fife, Terry D ^a,b  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VALPROIC ACID;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG WITHDRAWAL; EPILEPSY; FEMALE; HUMAN; LONG TERM CARE; NEUROPATHOLOGY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SHY DRAGER SYNDROME;

EID: 0034719037     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.12.1936     Document Type: Article

References (7)

1. Reversible parkinsonism and cognitive impairment with chronic valproate use
2. Reversible valproate-induced extrapyramidal disorders
3. Reversible cortical atrophy and cognitive decline induced by valproic acid
4. Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment
5. Parkinsonian syndrome in childhood after sodium valproate administration
6. Reversible parkinsonism induced by prolonged treatment with valproate
7. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy